Rapid Micro Biosystems (RPID) Total Current Liabilities (2020 - 2026)

Rapid Micro Biosystems has reported Total Current Liabilities for 7 years, with the latest figure at $19.1 million in Q1 2026.

• Quarterly Total Current Liabilities rose 27.49% year-over-year to $19.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.1 million (up 27.49% YoY) and the FY2025 annual result came in at $18.5 million, up 5.25% from the prior year.
• Total Current Liabilities grew to $19.1 million in Q1 2026 per RPID's latest filing, from $18.5 million in the prior quarter.
• Over five years, Total Current Liabilities peaked at $19.1 million in Q1 2026 and troughed at $12.8 million in Q2 2022.
• A 5-year average of $16.2 million and a median of $15.9 million in 2024 frame the typical range for Total Current Liabilities.
• The sharpest annual moves came in 2022 and 2026: Total Current Liabilities dropped 20.34% in 2022, then gained 27.49% in 2026.
• Over 5 years, Total Current Liabilities stood at $19.0 million in 2022, then declined by 0.34% to $19.0 million in 2023, then slipped by 7.48% to $17.6 million in 2024, then advanced by 5.25% to $18.5 million in 2025, then increased by 3.42% to $19.1 million in 2026.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $19.1 million, $18.5 million, and $16.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.